Literature DB >> 15648736

Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration.

Tobias Cantz1, Amar Deep Sharma, Andrea Jochheim-Richter, Lubomir Arseniev, Christoph Klein, Michael P Manns, Michael Ott.   

Abstract

We have investigated the contribution of intrasplenic bone marrow transplants or in vivo mobilized hematopoietic stem cells to the formation of hepatocytes in normal and injured liver. Direct intrasplenic injections of bone marrow mononuclear cells (5 x 10(5) cells), Scal+/lin- hematopoietic stem cells (5 x 10(3)) cells, and highly purified "side population" hematopoietic stem cells (5 x 10(3)) derived from enhanced green fluorescent protein (EGFP)-transgenic mice [C57Bl/6-TgN(ActbEGFP)1Osb] were performed in normal C57Bl/6 mice (n = 6) and in C57Bl/6 mice following two thirds hepatectomy (n = 8). To test the effect of mobilized stem cells on transdifferentiation, C57Bl/6 mice (n = 12) were lethally irradiated and reconstituted with EGFP-positive bone marrow mononuclear cells in a second series of experiments. Eight to 12 weeks after bone marrow transplantation a subset of mice (n = 3 in each group) received either rhG-CSF for hematopoietic stem cell mobilization, rhG-CSF combined with an intraperitoneal application of carbon tetrachloride (CCl4) as hepatocyte regeneration stimulus, or CCl4 alone. All mice were completely perfused with PBS to remove circulating nonorgan cells for analyses 4 weeks later. Liver as well as heart, intestine, spleen, and kidney tissue was analyzed for the presence of EGFP-transgenic cells. In 100 sections (2.3 x 10(7) cells) of any recipient mouse no EGFP-positive hepatocytes were detected either by analysis of native EGFP fluorescence or by immunofluorescence analysis with anti-EGFP and antidipeptidyl peptidase (DPP) IV antibodies. EGFP-transgenic cells resembling heart, kidney, or intestinal cells could also not be proven. The results demonstrate that there is little or no contribution of bone marrow-derived cells to the regeneration of normal and injured liver in the animal models used. Thus, potential therapeutic prospects of hematopoietic stem cell therapy for liver disease have to be critically reassessed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15648736     DOI: 10.3727/000000004783983521

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  17 in total

1.  New concepts in liver regeneration.

Authors:  Kimberly J Riehle; Yock Y Dan; Jean S Campbell; Nelson Fausto
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

Review 2.  Stem cells for liver tissue repair: current knowledge and perspectives.

Authors:  Philippe A Lysy; David Campard; Françoise Smets; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 3.  What is the real contribution of extrahepatic cells to liver regeneration?

Authors:  Susumu Eguchi; Takashi Kanematsu
Journal:  Surg Today       Date:  2009-01-08       Impact factor: 2.549

Review 4.  Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.

Authors:  Mukaddes Esrefoglu
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

5.  Differential bone marrow hematopoietic stem cells mobilization in hepatectomized patients.

Authors:  Carmen Herencia; Antonio Rodríguez-Ariza; Antonio Canalejo; Alvaro Naranjo; F Javier Briceño; Pedro López-Cillero; Manuel De la Mata; Juan R Muñoz-Castañeda
Journal:  J Gastrointest Surg       Date:  2011-04-22       Impact factor: 3.452

Review 6.  Potentials of regenerative medicine for liver disease.

Authors:  Shinichiro Ogawa; Shinichi Miyagawa
Journal:  Surg Today       Date:  2009-12-08       Impact factor: 2.549

7.  Recellularization of rat liver scaffolds by human liver stem cells.

Authors:  Victor Navarro-Tableros; Maria Beatriz Herrera Sanchez; Federico Figliolini; Renato Romagnoli; Ciro Tetta; Giovanni Camussi
Journal:  Tissue Eng Part A       Date:  2015-04-29       Impact factor: 3.845

8.  Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice.

Authors:  Dhivya Haridass; Qinggong Yuan; Pablo D Becker; Tobias Cantz; Marcus Iken; Michael Rothe; Nidhi Narain; Michael Bock; Miriam Nörder; Nicolas Legrand; Heiner Wedemeyer; Kees Weijer; Hergen Spits; Michael P Manns; Jun Cai; Hongkui Deng; James P Di Santo; Carlos A Guzman; Michael Ott
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

9.  Granulocyte colony-stimulating factor supports liver regeneration in a small-for-size liver remnant mouse model.

Authors:  Daniel Inderbitzin; Guido Beldi; Daniel Sidler; Peter Studer; Adrian Keogh; Sonja Bisch-Knaden; Rosy Weimann; Andreas Kappeler; Beat Gloor; Daniel Candinas
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.452

Review 10.  Stem cells in liver regeneration and therapy.

Authors:  Tobias Cantz; Michael P Manns; Michael Ott
Journal:  Cell Tissue Res       Date:  2007-09-28       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.